BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34291585)

  • 21. Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma.
    Dono M; Angelini G; Cecconi M; Amaro A; Esposito AI; Mirisola V; Maric I; Lanza F; Nasciuti F; Viaggi S; Gualco M; Bandelloni R; Truini M; Coviello DA; Zupo S; Mosci C; Pfeffer U
    Br J Cancer; 2014 Feb; 110(4):1058-65. PubMed ID: 24423917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular and immunohistochemical analyses of uveal melanoma patient cohort.
    Sarubi HC; Pereira NB; Gomes CC; Gomez RS; Carmo ACM; Melo FM; Bastos-Rodrigues L; Pedrosa MS; Friedman E; De Marco L
    Melanoma Res; 2019 Jun; 29(3):248-253. PubMed ID: 30480620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system.
    van de Nes J; Gessi M; Sucker A; Möller I; Stiller M; Horn S; Scholz SL; Pischler C; Stadtler N; Schilling B; Zimmer L; Hillen U; Scolyer RA; Buckland ME; Lauriola L; Pietsch T; Waha A; Schadendorf D; Murali R; Griewank KG
    J Neurooncol; 2016 May; 127(3):435-44. PubMed ID: 26744134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pyrophosphorolysis-activated polymerization detects circulating tumor DNA in metastatic uveal melanoma.
    Madic J; Piperno-Neumann S; Servois V; Rampanou A; Milder M; Trouiller B; Gentien D; Saada S; Assayag F; Thuleau A; Nemati F; Decaudin D; Bidard FC; Desjardins L; Mariani P; Lantz O; Stern MH
    Clin Cancer Res; 2012 Jul; 18(14):3934-41. PubMed ID: 22645051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Locus-specific concordance of genomic alterations between tissue and plasma circulating tumor DNA in metastatic melanoma.
    Calapre L; Giardina T; Robinson C; Reid AL; Al-Ogaili Z; Pereira MR; McEvoy AC; Warburton L; Hayward NK; Khattak MA; Meniawy TM; Millward M; Amanuel B; Ziman M; Gray ES
    Mol Oncol; 2019 Feb; 13(2):171-184. PubMed ID: 30312528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of metastases using circulating tumour DNA in uveal melanoma.
    Beasley AB; de Bruyn DP; Calapre L; Al-Ogaili Z; Isaacs TW; Bentel J; Reid AL; Dwarkasing RS; Pereira MR; Khattak MA; Meniawy TM; Millward M; Brosens E; de Klein A; Chen FK; Kiliҫ E; Gray ES
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14953-14963. PubMed ID: 37608028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner.
    Khalili JS; Yu X; Wang J; Hayes BC; Davies MA; Lizee G; Esmaeli B; Woodman SE
    Clin Cancer Res; 2012 Aug; 18(16):4345-55. PubMed ID: 22733540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of oncogenic GNAQ mutations in melanocytic lesions of the conjunctiva as compared to uveal melanoma.
    Dratviman-Storobinsky O; Cohen Y; Frenkel S; Pe'er J; Goldenberg-Cohen N
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6180-2. PubMed ID: 20631239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneity of GNAQ/11 mutation inversely correlates with the metastatic rate in uveal melanoma.
    Liang C; Peng LY; Zou M; Chen X; Chen Y; Chen H; Xiao L; Yan N; Zhang J; Zhao Q; Huang X
    Br J Ophthalmol; 2021 Apr; 105(4):587-592. PubMed ID: 31533929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma.
    Patrone S; Maric I; Rutigliani M; Lanza F; Puntoni M; Banelli B; Rancati S; Angelini G; Amaro A; Ligorio P; Defferrari C; Castagnetta M; Bandelloni R; Mosci C; DeCensi A; Romani M; Pfeffer U; Viaggi S; Coviello DA
    Genes Chromosomes Cancer; 2018 Aug; 57(8):387-400. PubMed ID: 29689622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes.
    Decatur CL; Ong E; Garg N; Anbunathan H; Bowcock AM; Field MG; Harbour JW
    JAMA Ophthalmol; 2016 Jul; 134(7):728-33. PubMed ID: 27123562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolutionary Routes in Metastatic Uveal Melanomas Depend on
    Rodrigues M; Mobuchon L; Houy A; Alsafadi S; Baulande S; Mariani O; Marande B; Ait Rais K; Van der Kooij MK; Kapiteijn E; Gassama S; Gardrat S; Barnhill RL; Servois V; Dendale R; Putterman M; Tick S; Piperno-Neumann S; Cassoux N; Pierron G; Waterfall JJ; Roman-Roman S; Mariani P; Stern MH
    Clin Cancer Res; 2019 Sep; 25(18):5513-5524. PubMed ID: 31227496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioinformatics analysis of GNAQ, GNA11, BAP1, SF3B1,SRSF2, EIF1AX, PLCB4, and CYSLTR2 genes and their role in the pathogenesis of Uveal Melanoma.
    Akin-Bali DF
    Ophthalmic Genet; 2021 Dec; 42(6):732-743. PubMed ID: 34353217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of Copy-Number Variation in Circulating Cell-Free DNA in Patients With Uveal Melanoma.
    Sato T; Montazeri K; Gragoudas ES; Lane AM; Aronow MB; Cohen JV; Boland GM; Banks E; Kachulis C; Fleharty M; Cibulskis C; Lawless A; Adalsteinsson VA; Sullivan RJ; Kim IK
    JCO Precis Oncol; 2024 Jan; 8():e2300368. PubMed ID: 38237100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microarray-based analysis of the BRAF V600 mutations in circulating tumor DNA in melanoma patients.
    Emelyanova MA; Telysheva EN; Orlova KV; Ryabaya OO; Snigiryova GP; Abramov IS; Mikhailovich VM
    Cancer Genet; 2021 Jan; 250-251():25-35. PubMed ID: 33249369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical and molecular pathology of ocular uveal melanocytoma: evidence for somatic GNAQ mutations.
    Mudhar HS; Doherty R; Salawu A; Sisley K; Rennie IG
    Br J Ophthalmol; 2013 Jul; 97(7):924-8. PubMed ID: 23685997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations.
    Chen X; Wu Q; Tan L; Porter D; Jager MJ; Emery C; Bastian BC
    Oncogene; 2014 Sep; 33(39):4724-34. PubMed ID: 24141786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monosomy 3 Influences Epithelial-Mesenchymal Transition Gene Expression in Uveal Melanoma Patients; Consequences for Liquid Biopsy.
    Soltysova A; Sedlackova T; Dvorska D; Jasek K; Chokhachi Baradaran P; Horvathova Kajabova V; Demkova L; Buocikova V; Kurucova T; Lyskova D; Furdova A; Minarik G; Babal P; Dankova Z; Smolkova B
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of unique MEK-dependent genes in GNAQ mutant uveal melanoma involved in cell growth, tumor cell invasion, and MEK resistance.
    Ambrosini G; Pratilas CA; Qin LX; Tadi M; Surriga O; Carvajal RD; Schwartz GK
    Clin Cancer Res; 2012 Jul; 18(13):3552-61. PubMed ID: 22550165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncogenic mutations in GNAQ occur early in uveal melanoma.
    Onken MD; Worley LA; Long MD; Duan S; Council ML; Bowcock AM; Harbour JW
    Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5230-4. PubMed ID: 18719078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.